ジャーナル論文 Characterization and evaluation of the ability of graphene quantum dots to affect α-synuclein aggregation in synucleinopathy models
Tuba Oz (author) (この著者で検索)
Poznan University of Medical Sciences a Department of Toxicology
;
Anna Alwani (author) (この著者で検索)
;
Agnieszka Kamińska (author) (この著者で検索)
;
Barbara Jachimska (author) (この著者で検索)
;
Makoto Timmon Tanaka (author) (この著者で検索)
;
Yasuo Miki (author) (この著者で検索)
;
Koichi Wakabayashi (author) (この著者で検索)
;
Katarzyna Maziarz (author) (この著者で検索)
;
Sheetal Kaushik Bhardwaj (author) (この著者で検索)
;
Ajeet Kaushik (author) (この著者で検索)
;
Małgorzata Figiel (author) (この著者で検索)
;
Piotr Chmielarz (author) (この著者で検索)
;
Małgorzata Kujawska (author) (この著者で検索)
コレクション

引用
Tuba Oz, Anna Alwani, Agnieszka Kamińska, Barbara Jachimska, Makoto Timmon Tanaka, Yasuo Miki, Koichi Wakabayashi, Katarzyna Maziarz, Sheetal Kaushik Bhardwaj, Ajeet Kaushik, Małgorzata Figiel, Piotr Chmielarz, Małgorzata Kujawska. Characterization and evaluation of the ability of graphene quantum dots to affect α-synuclein aggregation in synucleinopathy models. Science and Technology of Advanced Materials. 2026, 27 (1), 2662693. https://doi.org/10.1080/14686996.2026.2662693

説明:

(abstract)

Synucleinopathies, including Parkinson’s disease and multiple system atrophy (MSA), are neurodegenerative disorders characterized by aggregation of α-synuclein (ASN). Nanomaterials capable of modulating protein misfolding represent a potential intervention strategy. Here, we synthesized graphene quantum dots (GQDs) and systematically evaluated their physicochemical properties and biological activity against ASN aggregation. The GQDs were characterized using spectroscopic, electron microscopy, and colloidal techniques to determine surface chemistry, charge, optical properties, and crystalline structure. Biological evaluation demonstrated cytocompatibility in human dermal fibroblasts (IC50 = 90 µg mL−1 at 24 h) with assessments of DNA damage and inflammatory responses. Functionally, GQDs destabilized preformed ASN fibrils in a cell-free assay, as evidenced by reduced Thioflavin-T fluorescence. In primary murine dopaminergic neurons, GQDs decrease pS129-ASN inclusion formation without compromising neuronal viability. Most importantly, intranasal administration of GQDs in an MSA mouse model reduced ASN immunoreactivity in the brain. Collectively, our data indicate that the synthetized GQDs are bioactive and can modulate ASN aggregation across cell-free, neuronal, and in vivo models. Importantly, physicochemical properties govern nano – bio interactions, providing a rationale for further refinement of GQDs as a biomaterial platform for synucleinopathy-related applications.

権利情報:

キーワード: Graphene quantum dots, bioactive nanomaterials, Nano–bio interactions, amyloid inhibition, nanotoxicology, cytocompatibility, nano–bio interface

刊行年月日: 2026-12-31

出版者: Taylor & Francis

掲載誌:

  • Science and Technology of Advanced Materials (ISSN: 14686996) vol. 27 issue. 1 2662693

研究助成金:

原稿種別: 著者最終稿 (Accepted manuscript)

MDR DOI: https://doi.org/10.48505/nims.6305

公開URL: https://doi.org/10.1080/14686996.2026.2662693

関連資料:

その他の識別子:

連絡先:

更新時刻: 2026-05-21 11:41:20 +0900

MDRでの公開時刻: 2026-05-21 14:27:40 +0900

ファイル名 サイズ
ファイル名 Characterization and evaluation of the ability of graphene quantum dots to affect -synuclein aggregation in synucleinopathy models.pdf (サムネイル)
application/pdf
サイズ 7.25MB 詳細
ファイル名 STAM-2026-0043_data.zip
application/zip
サイズ 15MB 詳細